QQQ   416.98 (-1.52%)
AAPL   165.18 (-1.11%)
MSFT   399.41 (-1.20%)
META   483.15 (-3.72%)
GOOGL   153.96 (-1.31%)
AMZN   174.80 (-2.47%)
TSLA   148.83 (-0.73%)
NVDA   812.71 (-4.02%)
AMD   148.84 (-4.02%)
NIO   3.84 (-4.00%)
BABA   68.66 (-0.32%)
T   16.37 (+0.24%)
F   12.12 (+0.50%)
MU   107.74 (-3.74%)
GE   149.35 (-2.35%)
CGC   8.10 (+3.45%)
DIS   112.00 (-0.38%)
AMC   3.24 (+10.96%)
PFE   25.79 (+1.58%)
PYPL   62.22 (+0.19%)
XOM   120.22 (+1.43%)
QQQ   416.98 (-1.52%)
AAPL   165.18 (-1.11%)
MSFT   399.41 (-1.20%)
META   483.15 (-3.72%)
GOOGL   153.96 (-1.31%)
AMZN   174.80 (-2.47%)
TSLA   148.83 (-0.73%)
NVDA   812.71 (-4.02%)
AMD   148.84 (-4.02%)
NIO   3.84 (-4.00%)
BABA   68.66 (-0.32%)
T   16.37 (+0.24%)
F   12.12 (+0.50%)
MU   107.74 (-3.74%)
GE   149.35 (-2.35%)
CGC   8.10 (+3.45%)
DIS   112.00 (-0.38%)
AMC   3.24 (+10.96%)
PFE   25.79 (+1.58%)
PYPL   62.22 (+0.19%)
XOM   120.22 (+1.43%)
QQQ   416.98 (-1.52%)
AAPL   165.18 (-1.11%)
MSFT   399.41 (-1.20%)
META   483.15 (-3.72%)
GOOGL   153.96 (-1.31%)
AMZN   174.80 (-2.47%)
TSLA   148.83 (-0.73%)
NVDA   812.71 (-4.02%)
AMD   148.84 (-4.02%)
NIO   3.84 (-4.00%)
BABA   68.66 (-0.32%)
T   16.37 (+0.24%)
F   12.12 (+0.50%)
MU   107.74 (-3.74%)
GE   149.35 (-2.35%)
CGC   8.10 (+3.45%)
DIS   112.00 (-0.38%)
AMC   3.24 (+10.96%)
PFE   25.79 (+1.58%)
PYPL   62.22 (+0.19%)
XOM   120.22 (+1.43%)
QQQ   416.98 (-1.52%)
AAPL   165.18 (-1.11%)
MSFT   399.41 (-1.20%)
META   483.15 (-3.72%)
GOOGL   153.96 (-1.31%)
AMZN   174.80 (-2.47%)
TSLA   148.83 (-0.73%)
NVDA   812.71 (-4.02%)
AMD   148.84 (-4.02%)
NIO   3.84 (-4.00%)
BABA   68.66 (-0.32%)
T   16.37 (+0.24%)
F   12.12 (+0.50%)
MU   107.74 (-3.74%)
GE   149.35 (-2.35%)
CGC   8.10 (+3.45%)
DIS   112.00 (-0.38%)
AMC   3.24 (+10.96%)
PFE   25.79 (+1.58%)
PYPL   62.22 (+0.19%)
XOM   120.22 (+1.43%)
Free Trial

Neoleukin Therapeutics (NLTX) News Today

→ Biden’s $374B Giveaway Into This Sector (From DTI) (Ad)
Free NLTX Stock Alerts
$31.58
-2.06 (-6.12%)
(As of 04/18/2024 ET)
Compare
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media
SourceHeadline
marketbeat.com logoNeoleukin Therapeutics (NASDAQ:NLTX) Shares Down 0.8%
marketbeat.com - March 14 at 12:46 AM
finance.yahoo.com logoIs Neoleukin Therapeutics (NASDAQ:NLTX) In A Good Position To Invest In Growth?
finance.yahoo.com - December 20 at 9:16 AM
finance.yahoo.com logoNeoleukin Therapeutics Announces 1-for-4 Reverse Stock Split
finance.yahoo.com - December 15 at 12:06 AM
benzinga.com logoNeoleukin Therapeutics Stock (NASDAQ:NLTX) Dividends: History, Yield and Dates
benzinga.com - December 4 at 11:08 PM
markets.businessinsider.com logoPre-market Movers: ORTX, CMBM, GROM, RSVR, FEMY…
markets.businessinsider.com - October 5 at 8:10 AM
finanznachrichten.de logoNeoleukin Therapeutics, Inc.: Neoleukin Therapeutics Announces 1-for-5 Reverse Stock Split
finanznachrichten.de - September 26 at 8:11 AM
finance.yahoo.com logoNeoleukin Therapeutics Announces 1-for-5 Reverse Stock Split
finance.yahoo.com - September 22 at 8:21 AM
benzinga.com logoNeoleukin Therapeutics Recent Insider Activity
benzinga.com - August 18 at 4:56 PM
finance.yahoo.com logoBAKER BROS. ADVISORS LP Reduces Stake in Neoleukin Therapeutics Inc
finance.yahoo.com - August 18 at 4:56 PM
markets.businessinsider.com logoSHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AMNB, CCF, NLTX, SCU
markets.businessinsider.com - August 8 at 8:05 AM
markets.businessinsider.com logoSHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AJX, DEN, FREQ, NLTX
markets.businessinsider.com - August 1 at 6:57 AM
finance.yahoo.com logoRedmile Group, LLC Boosts Stake in Neoleukin Therapeutics Inc
finance.yahoo.com - July 28 at 11:02 AM
benzinga.com logoMoore Kuehn Encourages AMNB, SCU, NLTX, and PRDS Investors to Contact Law Firm
benzinga.com - July 26 at 7:36 PM
247wallst.com logoBaker Bros. Advisors Now Owns 19.99% of Neoleukin Therapeutics
247wallst.com - July 24 at 1:31 PM
markets.businessinsider.com logoNeurogene, Neoleukin Announce Planned Merger
markets.businessinsider.com - July 19 at 6:36 AM
msn.com logoUniv. of Washington spinout Neoleukin Therapeutics merging with New York City startup
msn.com - July 18 at 5:54 PM
finanznachrichten.de logoNeoleukin Therapeutics, Inc.: Neurogene and Neoleukin Announce Definitive Merger Agreement
finanznachrichten.de - July 18 at 12:53 PM
benzinga.com logoNeoleukin Therapeutics To Merge With Neurogene: Creates Biotech Firm Focused On Genetic Medicines For Neurological Diseases
benzinga.com - July 18 at 12:53 PM
markets.businessinsider.com logoSHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates DEN, NLTX, FREQ
markets.businessinsider.com - July 18 at 12:53 PM
msn.com logoNeoleukin jumps 7% on Neurogene merger
msn.com - July 18 at 7:52 AM
marketwatch.com logoNeoleukin Therapeutics Shares Rise Premarket on Reverse Merger Deal >NLTX
marketwatch.com - July 18 at 7:52 AM
technews.tmcnet.com logoNLTX Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Neoleukin Therapeutics, Inc. Is Fair to Shareholders
technews.tmcnet.com - July 18 at 7:52 AM
finance.yahoo.com logoNeurogene and Neoleukin Announce Definitive Merger Agreement
finance.yahoo.com - July 18 at 7:52 AM
finance.yahoo.com logoBiomed Industries, Inc. Offers to acquire Neoleukin Therapeutics, Inc. (NASDAQ:NLTX)
finance.yahoo.com - May 23 at 9:11 AM
markets.businessinsider.com logoMizuho Securities Reaffirms Their Hold Rating on Neoleukin Therapeutics (NLTX)
markets.businessinsider.com - May 9 at 8:53 AM
bizjournals.com logoNeoleukin Therapeutics promotes general counsel to interim CEO
bizjournals.com - April 7 at 2:43 AM
seekingalpha.com logoNLTX Neoleukin Therapeutics, Inc.
seekingalpha.com - March 31 at 3:34 PM
markets.businessinsider.com logoNeoleukin Therapeutics (NLTX) Receives a Hold from Mizuho Securities
markets.businessinsider.com - March 21 at 2:20 PM
finance.yahoo.com logoHere's Why We're Watching Neoleukin Therapeutics' (NASDAQ:NLTX) Cash Burn Situation
finance.yahoo.com - March 10 at 5:20 PM
bizjournals.com logoSeattle biotech company CEO steps down amid steep job cuts
bizjournals.com - March 10 at 4:28 AM
marketwatch.com logoNeoleukin Therapeutics Shares Climb 29% on 70% Workforce Reduction, Strategic Alternatives
marketwatch.com - March 9 at 6:27 PM
msn.com logoShares of Neoleukin Therapeutics spike after announcing layoffs and potential sale or merger
msn.com - March 9 at 6:27 PM
finance.yahoo.com logoNeoleukin Therapeutics Seeks Strategic Alternatives, To Layoff More In Round 2 Within 6 Months
finance.yahoo.com - March 9 at 6:27 PM
msn.com logoNeoleukin Therapeutics to cut 70% workforce, CEO steps down
msn.com - March 9 at 3:45 AM
marketwatch.com logoNeoleukin Therapeutics Eyes Strategic Alternatives, Will Cut Staff
marketwatch.com - March 8 at 10:36 PM
markets.businessinsider.com logoMizuho Securities Keeps Their Hold Rating on Neoleukin Therapeutics (NLTX)
markets.businessinsider.com - March 8 at 10:36 PM
finance.yahoo.com logoNeoleukin Therapeutics Provides Strategic Update and Announces Restructuring and Leadership Transition
finance.yahoo.com - March 8 at 5:36 PM
finance.yahoo.com logoNeoleukin Therapeutics Presents Preclinical Data on NEO-TRA1 at American Society of Hematology (ASH) Annual Meeting
finance.yahoo.com - December 12 at 4:33 PM
finance.yahoo.com logoNeoleukin (NLTX) Stops Development of Lead Drug, Stock Down
finance.yahoo.com - November 16 at 4:30 PM
markets.businessinsider.com logoMizuho Securities downgrades Neoleukin Therapeutics (NLTX) to a Hold
markets.businessinsider.com - November 15 at 10:07 PM
finance.yahoo.com logoNeoleukin Pauses Development Of NL-201, Cuts 40% Of Employee Strength
finance.yahoo.com - November 15 at 5:07 PM
seekingalpha.com logoNeoleukin cut to Hold at Stifel on plans to drop lead asset
seekingalpha.com - November 15 at 12:06 PM
markets.businessinsider.com logo5 Analysts Have This to Say About Neoleukin Therapeutics
markets.businessinsider.com - November 15 at 12:06 PM
finance.yahoo.com logoNeoleukin Therapeutics Announces Third Quarter 2022 Financial Results and Corporate Update
finance.yahoo.com - November 15 at 12:06 PM
marketbeat.com logo
marketbeat.com - November 14 at 4:03 PM
finance.yahoo.com logoNeoleukin Therapeutics Announces Oral Presentation at 64th American Society of Hematology (ASH) Annual Meeting
finance.yahoo.com - November 3 at 1:20 PM
finance.yahoo.com logoWe're Keeping An Eye On Neoleukin Therapeutics' (NASDAQ:NLTX) Cash Burn Rate
finance.yahoo.com - October 1 at 1:25 PM
seekingalpha.com logoNeoleukin Therapeutics, Inc. (NLTX) CEO Jonathan Drachman on Q2 2022 Results - Earnings Call Transcript
seekingalpha.com - August 10 at 3:05 AM
seekingalpha.com logoNeoleukin Therapeutics, Inc. 2022 Q2 - Results - Earnings Call Presentation
seekingalpha.com - August 10 at 1:20 AM
msn.com logoRecap: Neoleukin Therapeutics Q2 Earnings
msn.com - August 9 at 9:54 PM
Get Neoleukin Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for NLTX and its competitors with MarketBeat's FREE daily newsletter.

Urgent alert: open this for a huge profit potential (Ad)

This groundbreaking technology that Tim calls “Inception” isn’t being talked about anywhere… not on Fox, Yahoo, or CNBC.

See Tim’s instructions to make this remarkably simple trade right here

NLTX Media Mentions By Week

NLTX Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

NLTX
News Sentiment
▼
0.00

0.52
▲
Average
Medical
News Sentiment

NLTX News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

NLTX Articles
This Week
▼
0

0
▲
NLTX Articles
Average Week

Get Neoleukin Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for NLTX and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

Related Companies:
Headlines Tools:
This page (NASDAQ:NLTX) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners
Healthcare Takes A Big Step Forward With The Help Of AI
The Bull Report
The “Perfect Storm” for Gold
Gold Safe Exchange
The Best AI Stock to Own in the World Today is Trading for Just $25
Banyan Hill Publishing
Biden’s $374B Giveaway Into This Sector
DTI
The #1 Crypto for 2024
InvestorPlace
Did You Get Your Free Bitcoin Yet?
Crypto Swap Profits
Urgent alert: open this for a huge profit potential
Timothy Sykes
1970’s computer coder issues shocking A.I. warning
TradeSmith